Latest News  

Promising Treatment for Eosinophilic Granulomatosis with Polyangiitis

A recent study showed that patients with eosinophilic granulomatosis with polyangiitis taking mepolizumab had longer disease remission than those on placebo. Some patients were able to discontinue prednisone during the study… [Read More]

News Updates for Diclofenac Sodium, Denosumab & Sarilumab

In drug news, a generic 2% diclofenac sodium solution is now available, denosumab is promising to treat osteoporosis, and the FDA has approved sarilumab to treat adults with RA… [Read More]

FDA Requests Removal of Opana ER; Plus Abatacept’s New Dosing Option

The FDA has asked the manufactures of Opana ER to remove the opioid from the U.S. market due to the public health risk of abuse… [Read More]

U.S. Senators Worry about Rush over Healthcare Bill ahead of Release

WASHINGTON (Reuters)—U.S. senators expressed concern on Wednesday about a plan to overhaul the U.S. healthcare system, fearing a rush to consider the major legislation as… [Read More]

Missouri Sues Opioid Manufacturers, Joining Two other U.S. States

(Reuters)—Missouri on Wednesday became the third U.S. state to accuse major drug manufacturers of fraudulently misrepresenting the risks of opioid painkillers now at the center… [Read More]

U.S. FDA Moves to Prevent Pharma from “Gaming” Generic Drug System

WASHINGTON (Reuters)—The U.S. Food and Drug Administration moved on Wednesday to prevent pharmaceutical companies from “gaming” the system to block or delay entry of generic… [Read More]

View More Latest News »